Our preliminary results indicated that deletion of Pygo2 exerts different effects in early phases of intestinal tumor development in contrast to APCMin/+ mice, in which the formation of adenoma was not prevented by constitutive ablation of Pygo2 (Schelp and Brembeck, unpublished data). Here, PYGO2 is linked to intestinal neoplasm.